Compositions and methods for treating neoplastic diseases
AssigneesCelgene International II SÀRL, Dana-Farber Cancer Institute, Inc.
InventorsKenneth C. ANDERSON, Dharminder CHAUHAN, Michael A. PALLADINO
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
Claims37
A method of treating a neoplastic disease, comprising:
- administering to a patient inflicted with the neoplastic disease a compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof:
- wherein X is selected from the group consisting of fluorine, chlorine, bromine or iodine, and
- wherein the neoplastic disease is susceptible to resistance to at least one other chemotherapeutic agent.
A method of treating a neoplastic disease, comprising administering to a patient inflicted with the neoplastic disease a compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof:
- wherein X is selected from the group consisting of fluorine, chlorine, bromine or iodine, in combination with at least one additional chemotherapeutic agent.
A pharmaceutical composition, comprising:
- a compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof:
- wherein X is selected from the group consisting of fluorine, chlorine, bromine or iodine;
- and
- at least one additional chemotherapeutic agent.
A method of treating a neoplastic disease, comprising administering to a patient inflicted with the neoplastic disease a synergistic combination of at least two proteosome inhibitors.
Dependencies are inferred from the claim text.